UC San Diego Health Sciences schools, institutes and centers are at the forefront of discovery and transformation.
For Parkinson's patients, the drug that restores movement can stop working reliably and cause involuntary movements of its own. A new candidate from UC San Diego-born biotech Sinopia Biosciences may fix both — boosting L-dopa's benefits while easing dyskinesia.
The new Institute for Applied Health Intelligence at UC San Diego will connect resources across six schools and UC San Diego health to generate next-generation solutions for pressing challenges in medicine.
As America marks its 250th anniversary, discover nine surprising ways UC San Diego has contributed to the nation's history — from helping forecast D-Day to advancing lifesaving medicine, climate science and the technologies of tomorrow.
Researchers at UC San Diego have developed a large-scale screening approach that identifies proteins controlling a fundamental step in gene expression known as alternative polyadenylation (APA). APA determines where an RNA molecule is cut and finished before it is translated into protein.
New research from UC San Diego suggests that an existing drug, previously shelved in other contexts, could help control cholesterol.
Innovative project will use AI-powered “digital twins” to help public health agencies better prevent HIV, hepatitis C and overdose among people who use drugs.
New York Times, June 22
Fox Channel 5 News, June 16
San Diego Union Tribune, June 7
Keep up with all the latest from UC San Diego. Subscribe to the newsletter today.
